Biotech

All Articles

Lilly messages even more positive data on its own every week insulin prospect

.On the heels of an FDA rejection for its own primary competing Novo Nordisk, Eli Lilly is pushing o...

IN 8bio standstills period 2 test, lays off fifty percent of labor force

.Only a couple of months after dosing the 1st person in a phase 2 trial for newly identified gliobla...

Lilly, Haya ink $1B biobuck weight problems contract to browse black genome

.Eli Lilly's hunt for weight problems aim ats has led it to the black genome. The Big Pharma has pro...

ArsenalBio raises $325M, turns away from previous lead possession

.Toolbox Biosciences is moving on up. The cell therapy provider has added $325 million in ammo with ...

Lilly- backed effective weight loss biotech files IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' cannabis usage medication flunks stage 2b, steering Indivior to review $100M choice

.Aelis Farma's hopes of securing an easy, good choice on a $one hundred million possibility payment ...

ProKidney stops phase 3 trial not needed to have for cell treatment authorization

.ProKidney has actually ceased one of a pair of stage 3 tests for its tissue treatment for renal ail...

Vaxcyte rises on 'impressive' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals named "magnificent" phase 1/2 information for its own 31-valent...

Recursion's human brain health condition trial presents insufficient documentation of efficacy

.Recursion has actually discovered with a very early examination of its own tech-enabled approach to...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Phone it an instance of great chemical make up: Acepodia, a biotech based on Nobel Prize-winning sc...